National Health (Listed drugs on F1 or F2) Amendment Determination 2011
Instrument number PB 9 of 2011
as amended
made under subsection 85AB (1) of the
National Health Act 1953
This compilation was prepared on 1 February 2011
[This Determination (PB 9 of 2011) was amended by PB 19 of 2011 (see F2011L00172)]
Amendment made by PB 19 of 2011
[Schedule 1 (item 1) amended subsection 1 (1) of the National Health (Listed drugs on
F1 or F2) Amendment Determination 2010)
Schedule 1 (item 1) amended the citation and commenced on 1 February 2011, immediately after the commencement of PB 9 of 2011.]
Prepared by the Office of Legislative Drafting and Publishing,
Attorney-General’s Department, Canberra
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination2011.
(2) This Determination may also be cited as PB 9 of 2011.
2 Commencement
This Determination commences on 1 February 2011.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids
Insert
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides
[2] Schedule 1, after item dealing with Aurothiomalate
Insert
Azacitidine
[3] Schedule 1, after item dealing with Duloxetine
Insert
Dutasteride
[4] Schedule 1, after item dealing with Ustekinumab
Omit
Valaciclovir
[5] Schedule 2, after item dealing with Calcitriol
Omit
Clarithromycin
[6] Schedule 2, after item dealing with Clarithromycin
Insert
Clindamycin
[7] Schedule 2, after item dealing with Perindopril
Insert
Perindopril with amlodipine
[8] Schedule 2, after item dealing with Trimethoprim with sulfamethoxazole
Insert
Valaciclovir